Articles By Cyndi Root

  1. U.S. House Committee Demands That Gilead Justify The Cost of Sovaldi 3/31/2014

    House Democrats have sent a letter to Gilead Sciences demanding that the pharmaceutical company justify the price of its new drug, Sovaldi.

  2. Physicians Protest FDA's Rejection Of Genzyme's Lemtrada For Multiple Sclerosis 3/31/2014

    The doctors who participated in clinical trials of Lemtrada, a multiple sclerosis (MS) drug, are protesting the Food and Drug Administration’s (FDA) decision to reject the medication.

  3. Alcobra Begins Phase III Trial For MDX In ADHD 3/27/2014

    Alcobra Ltd. announced via press release that it has begun a Phase III trial for Metadoxine Extended Release (MDX).

  4. FDA Says PharmaRoth's Sucanon Is A Drug, Not A Neutraceutical 3/26/2014

    PharmaRoth Labs, Inc., formerly Fero Industries, Inc., announced that the Food and Drug Administration (FDA) has reclassified its diabetes agent, Sucanon, as a drug.

  5. FDA Approves Endo's Aveed Testosterone Replacement For Male Hypogonadism 3/25/2014

    Endo International announced in a press release that the Food and Drug Administration (FDA) has approved the Aveed injection.

  6. FDA Approves Mallinckrodt's Xartemis For Pain 3/25/2014

    Mallinckrodt Pharmaceuticals announced via press release that the Food and Drug Administration (FDA) has approved Xartemis XR.

  7. Weekly FDA Enforcement Report For Drugs And Biologics 3/24/2014

    The Food and Drug Administration (FDA) has released its Drug and Biological product Enforcement Report for March 19, 2014.

  8. FDA Accepts Application For Regeneron's Eylea Injection For Macular Edema 3/19/2014
  9. Transparency Market Research 2013 – 2019 Pediatric Drugs Market Report 3/14/2014

    Transparency Market Research company has released a report detailing the global pediatric drug marketplace. The industry is growing as disease incidence is rising, parents are demanding better drugs, governments are improving regulations and funding new programs, and pharmaceutical companies are investing in this niche market.

  10. Weekly FDA Enforcement Report For Drugs And Biologics 3/5/2014

    The Food and Drug Administration (FDA) has released its Drug and Biological product Enforcement Report for February 26, 2014.